Total Funding
45
62
Total FundingFunding Round raised
Growth Score 45 in past quarter
-6 pts
Heat Score 62 in past quarter
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
28602
Receptor.AI - AI-accelerated drug discovery
- Sergii Starosyla: CTO & Co-Founder
- Semen Yesylevskyy: Chief Scientific OfficerPast Role: University of Franche-Comté, Research fellow
About the Company
Receptor AI is a TechBio drug discovery company advancing complex therapeutic programs through an integrated AI-powered discovery ecosystem. The platform combines multi-modal molecule design with a modality-agnostic decision engine to define optimal therapeutic strategies, prioritize high-confidence candidates, and guide programs toward IND and
clinical development. Receptor AI supports discovery and optimization across small molecules, peptides, antibodies, and PPI modulators, helping pharma and biotech partners address complex target biology with greater speed, precision, and translational confidence. Its technology has been validated across 40+ discovery programs and is guided by experts behind FDA-approved and clinical-stage medicines.